
Please try another search
HLB SCIENCE Inc. develops biological drugs with MoA to infectious diseases. Its pipeline includes DD-S052P, a candidate that exterminates germs and eliminates endotoxins; DD-A279, a new treatment to cure Alzheimer's Diseases by controlling LPS and Gram-negative bacteria; and DD-A514, a diagnosis kit for Alzheimer's diseases. The company was formerly known as Dandi Bio Science Co.,Ltd. and changed its name to HLB SCIENCE Inc. in March 2023. The company was founded in 2016 and is based in Seoul, South Korea.
Name | Age | Since | Title |
---|---|---|---|
Hyung Wook Kim | - | - | Member of Scientific Advisory Board |
Yoon Jongsun | 59 | - | CEO & Director |
Young Kyung Yoon | - | - | Member of Scientific Advisory Board |
Yangmee Kim | - | - | Member of Scientific Advisory Board |
Dong-Gun Lee | - | - | Member of Scientific Advisory Board |
Sang Koo Lee | - | - | Member of Scientific Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review